CXCL12 and breast cancer: Prolonged exposure (30 days) of human bone marrow-derived mesenchymal stem cells to conditioned media from MDA-MB-231 breast cancer cells resulted in myofibroblast differentiation, characterized by high expression of α-SMA, vimentin, fibroblast surface protein (FSP) and SDF-1 [53].